In older patients with AF and frailty, switching from VKA to NOAC therapy increased a composite of major or CRNM bleeding at 12 mo.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 38710082.
- Also identified by DOI 10.7326/J24-0024.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Joosten LP, van Doorn S, van de Ven PM, et al. <b>Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial.</b> Circulation. 2024;149:279-289. 37634130.
Medical subject headings
- Anticoagulants
- Atrial Fibrillation
- Hemorrhage
- Vitamin K